COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,082 Articles (22,658 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 1383: Articles 13821-13830  | Next

Transmission dynamics of COVID-19 in Ghana and the impact of public health interventions
Ofori, S. K., Schwind, J. S., Sullivan, K. L., Cowling, B. J., Chowell, G., Fung, I. C.-H.
10.1101/2021.07.04.21259991 — Posted: 2021-07-06
Predictors of hospitalisation and death due to SARS-CoV-2 infection in Finland: a population-based register study with implications to vaccinations
Salo, H., Lehtonen, T., Auranen, K., Baum, U., Leino, T.
10.1101/2021.07.04.21259954 — Posted: 2021-07-06
Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City
Duerr, R., Dimartino, D., Marier, C., Zappile, P., Wang, G., Lighter, J., Elbel, B., Troxel, A., Heguy, A.
10.1101/2021.07.05.21259547 — Posted: 2021-07-06
Whole-genome sequencing of SARS-COV-2 reveals a substantially lower frequency of the UK variant than previously announced in Libya
Alhudiri, I. M., Ramadan, A. M., Ibrahim, K. I., Eljilani, M., Aboud, A. A., Salem, M. A., Elgheriani, H. M., Elzagheid, A.
10.1101/2021.07.03.21257942 — Posted: 2021-07-06
High Seroprevalence of anti-SARS-CoV-2 antibodies among Ethiopian healthcare workers
Gelanew, T., Seyoum, B., Mulu, A., Mihret, A., Abebe, M., Wassie, L., Gelaw, B., Sorsa, A., Merid, Y., Muchie, Y., Teklemariam, Z., Tesfaye, B., Osman, M., Jebessa, G., Atinafu, A., Hailu, T., Habte, A., Kenea, D., Gadissa, A., Admasu, D., Tesfaye, E., Bates, T. A., Bulcha, J., Tschopp, R., Tsehay, D., Mullholand, k., Howe, R., Gentu, A., Tafesse, F. G., Abdissa, A.
10.1101/2021.07.01.21259687 — Posted: 2021-07-06
Individual-Level Heterogeneity in Mask-wearing During the COVID-19 Pandemic in Malaysia
Zhang, S. X., Looi, K. H., Li, N., LI, J., Wan, X.
10.1101/2021.07.02.21257837 — Posted: 2021-07-06
Humoral and cellular responses to mRNA vaccines against SARS-CoV2 in patients with a history of CD20-B-cell depleting therapy
Moor, M. B., Suter-Riniker, F., Horn, M. P., Aeberli, D., Amsler, J., Moeller, B., Njue, L. M., Medri, C., Angelillo-Scherrer, A., Borradori, L., Radonjic-Hoesli, S., Chan, A., Hoepner, R., Bacher, V. U., Mani, L.-Y., Iype, J. M., Hirzel, C., Maurer, B., Sidler, D.
10.1101/2021.07.04.21259848 — Posted: 2021-07-06
A cross-sectional cohort study of prevalence of antibodies to COVID-19 in Port-au-Prince, Haiti
DEGENNARO, V., Henderson, R., Schwartz, T., Elie, M.-C.
10.1101/2021.06.30.21259815 — Posted: 2021-07-06
Sex- and Gender-specific Risk Factors of Post-COVID-19 Syndrome: A Population-based Cohort Study in Switzerland
Gebhard, C. E., Suetsch, C., Bengs, S., Deforth, M., Buehler, K. P., Nadia Hamouda, N., Meisel, A., Schuepbach, R. A., Zinkernagel, A. S., Brugger, S. D., Acevedo, C., Patriki, D., Wiggli, B., Beer, J. H., Friedl, A., Twerenbold, R., Kuster, G. M., Pargger, H., Tschudin-Sutter, S., Schefold, J. C., Spinetti, T., Dussault-Cloutier, A., Henze, C., Pasqualini, M., Sager, D. F., Mayrhofer, L., Grieder, M. C., Tontsch, J., Franzeck, F., Wendel Garcia, P. D., Hofmaenner, D. A., Scheier, T., Bartussek, J. D., Chrobok, L., Staehli, D., Lott, N., Graemer, M., Mikail, N., Rossi, A., Zellweger, N., Opic, P., Portmann, A., Todorov, A., Pazhenkottil, A. P., Messerli, M., Haider, A., Buechel, R. R., Kaufmann, P. A., Treyer, V., Siegemund, M., Held, U., Regitz-Zagrosek, V., Gebhard, C.
10.1101/2021.06.30.21259757 — Posted: 2021-07-06
SARS-CoV-2 B.1.1.7 lineage rapidly spreads and overwhelms R.1 lineage in Japan: serial and stationary observation in a community
Hirotsu, Y., Omata, M.
10.1101/2021.06.30.21259820 — Posted: 2021-07-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).